Drug interactions with new hepatitis C oral drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug interactions with new hepatitis C oral drugs

Published:2015-01-02 Issue:3 Volume:11 Page:333-341
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Soriano Vincent,Labarga Pablo,Barreiro Pablo,Fernandez-Montero José V,de Mendoza Carmen,Esposito Isabella,Benítez-Gutiérrez Laura,Peña José M

Publisher

Informa Healthcare

Subject

Pharmacology,Toxicology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/17425255.2015.998997

Reference46 articles.

1. Global epidemiology and genotype distribution of the hepatitis C virus infection

2. EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

3. EASL Recommendations on Treatment of Hepatitis C 2014

4. Pharmacokinetics of new oral hepatitis C antiviral drugs

5. Current prospects for interferon-free treatment of hepatitis C in 2012

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comorbidities and Contraindicated Medications in Patients with Chronic Hepatitis C Infection in Japan: a Real-World Database Study;Kanzo;2024-08-01

2. In‐depth investigation of the Silymarin effect on the pharmacokinetic parameters of sofosbuvir, GS‐331007 and ledipasvir in rat plasma using LC–MS;Biomedical Chromatography;2022-06-23

3. In Vitro Assessment of Transporter Mediated Perpetrator DDIs for Several Hepatitis C Virus Direct-Acting Antiviral Drugs and Prediction of DDIs with Statins Using Static Models;The AAPS Journal;2022-03-21

4. Evaluation of Ribavirin–Poloxamer Microparticles for Improved Intranasal Absorption;Pharmaceutics;2021-07-23

5. Virus-associated ribozymes and nano carriers against COVID-19;Artificial Cells, Nanomedicine, and Biotechnology;2021-01-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3